(University of South Florida) C-peptide has the potential to be a validated endpoint for DMT clinical trials, and researchers like Dr
Application & Images Applications M01019-1 is guaranteed for IP, IHC, WB Boster Guarantee Recommend Dilution WB 1:500-2000 IHC 1:50-200 IP 1:20 Tested application GPX1 antibody was positively detected by WB in: human 293T whole cell, human THP-1 whole cell, human HepG2 whole cell, rat liver tissue, mouse liver tissue Suggested blocking solution with 5% non-fat milk or BSA
Karges gratefully acknowledges the financial support provided by the Liebig fellowship from the Chemical Industry Fund of the German Chemical Industry Association, the Life Sciences Bridge Award from the Aventis Foundation, and the Paul Ehrlich & Ludwig Darmstaedter Early Career Award 2024 a prize awarded by the Paul Ehrlich Foundation, Germany
Very few have used it that long outside of clinical trials, so rare or late risks are not fully known
%25201.png)
